News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Results>CSPC PHARMA Annual NP RMB4.328B, Down 26.3%; Final Div. Cut to HK10 Cents
CSPC PHARMA (01093.HK) has announced its annual results for the year ended December 2024. The company's turnover declined by 7.8% YoY to RMB29.009 billion, while its net profit...
Reset
Send
The window will close in 5 seconds
<Results>CSPC PHARMA Annual NP RMB4.328B, Down 26.3%; Final Div. Cut to HK10 Cents
Close
Recommend
20
Positive
24
Negative
15
 
 

CSPC PHARMA (01093.HK)  -0.030 (-0.435%)    Short selling $134.03M; Ratio 30.909%   has announced its annual results for the year ended December 2024. The company's turnover declined by 7.8% YoY to RMB29.009 billion, while its net profit amounted to RMB4.328 billion, down 26.3% YoY, with EPS standing at RMB36.87 cents. Its GPM also edged down by 0.5 ppts to 70.0%.

Dividend History
Announce DateEventParticular
2024/11/153rd QuarterlyNo Dividend
2024/08/21InterimD:HKD 0.1600
2024/05/271st QuarterlyNo Dividend
2024/03/20FinalD:HKD 0.1400

A final dividend of HK10 cents was declared, compared to HK14 cents in the corresponding period of the previous year. Together with the interim dividend, the full-year dividend reached HK26 cents, compared to HK28 cents for the entire previous year.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-28 12:25.)
AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.